Skip to main content
Take Quiz
Male physician holding the Revi device between his fingers while talking to patient out of view.
Male physician holding the Revi device between his fingers while talking to patient out of view.
Revi.

Key into the RESTORE Clinical Study

Male physician holding the Revi device between his fingers while talking to patient out of view.
Male physician holding the Revi device between his fingers while talking to patient out of view.

Discover the future of treatment for urgent bladder leaks:

The RESTORE clinical study plays a pivotal role in advancing research for people with urge urinary incontinence, also known as urgent bladder leaking. This study offers the opportunity to access the transformational treatment of the Revi® System, which includes a miniature device that is implanted near the ankle to send signals through the nerves to the bladder. The signal can be adjusted, providing personalized therapy that is conveniently delivered where and when you want it.

Evaluation of your bladder symptoms from a participating doctor

The Revi System and all study-related care are at no cost

The opportunity to help advance bladder research and potentially benefit others who suffer from urgent bladder leaks

Proven Treatment, Proven Results

In a previous clinical study, Revi demonstrated high patient satisfaction and a significant decrease in the number of urgent bladder leaks in those who completed 1-year of the study. In fact, 50% of participants were without leaks or accidents for 3 consecutive days.1

95%

95% of study participants in a major study were satisfied with Revi therapy*

82%

82% of participants had more than a 50% reduction in incontinence episodes*

Interested in learning
more about Revi?

*Completers analysis represents the 139 patients with available data at 12 months. Satisfaction results are from the 130 patients who completed the survey.

For further information on the OASIS study and other on-going clinical studies, please visit clinicaltrials.gov (OASIS NCT03596671)

References:

1. Heesakkers, J.et al. (2023, April 30). Pivotal Study of a Novel Wirelessly Powered, Patient Tailored Programmed, Tibial Neurostimulator for the Treatment of Patients with Overactive Bladder. AUA 2023.